← SynDRA
EVENAMIDE
SynDRA canonical compound SYN0038387 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | SCN10A | SCN3A | SCN9A |
|---|
| Mechanism of action | voltage-gated sodium channel blocker |
|---|
All known targets
- SCN10A
- SCN3A
- SCN9A
- SCN11A
- SCN1A
- SCN2A
- SCN4A
- SCN5A
- SCN7A
- SCN8A
Mechanisms of action (all sources)
- SCN1A BLOCKER
- Sodium channel alpha subunit blocker
- SCN5A BLOCKER
- SCN4A BLOCKER
- SCN7A BLOCKER
- SCN2A BLOCKER
- SCN9A BLOCKER
- SCN3A BLOCKER
- SCN11A BLOCKER
- SCN8A BLOCKER
- SCN10A BLOCKER
- voltage-gated sodium channel blocker
Cross-references
Synonyms
- Evenamida
- Nw-3509
- NW-3509
- NW-3381
- Sodium channel blockers (epilepsy/pain/mania), Newron
- 2-((3-Butoxyphenethyl)amino)-N,N-dimethylacetamide
- UNII-ON5S6N53JS
- ON5S6N53JS
- MFCD28502433
- 2-[(3-Butoxyphenethyl)amino]-N,N-dimethylacetamide
- Evenamide [INN]
- SCHEMBL3025285
- CHEMBL3678076
- 2-((2-(3-Butoxyphenyl)ethyl)amino)-N,N-dimethylacetamide
- Acetamide, 2-((2-(3-butoxyphenyl)ethyl)amino)-N,N-dimethyl-
- BDBM161090
- SB18910
- AS-48527
- HY-17612
- SY244487
- CS-0014697
- Q21098995
- 2-[2-(3-butoxyphenyl)ethylamino]-N,N-dimethylacetamide
- US9051240, 2-[2-(3-Butoxyphenyl)-ethylamino]-N,N-dimethylacetamide
- evenamida
- EVENAMIDE [WHO-DD]
- 2-[[2-(3-Butoxyphenyl)ethyl]amino]-N,N-dimethylacetamide
- evenamidum
- RefChem:139668
- Evenamid
- orb1308318
- SCHEMBL29389974
- EX-A9007
- STB97761
- XH1604
- AKOS027335779
- AC-35786
- F50592
- T15260
Look up EVENAMIDE in the interactive SynDRA portal →